Status:
RECRUITING
Preventive Effect of Perinatal Oral Probiotic Supplementation (POPS) on Neonatal Jaundice
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Neonatal Jaundice
Microtia
Eligibility:
FEMALE
18-45 years
Phase:
PHASE2
Brief Summary
This is a randomized double-blind placebo-controlled parallel group superiority clinical trial among 94 pregnant women (47 in each group) to investigate the effect of maternal perinatal probiotic supp...
Detailed Description
Neonatal jaundice is a yellowish discoloration of the skin and sclera because of over-concentration of circulating unconjugated bilirubin (hyperbilirubinemia) in the body. It can lead the baby to seve...
Eligibility Criteria
Inclusion
- All pregnant women aged 18-45 years old.
- Gestational age of 28-34 weeks
- Normal singleton pregnancy
Exclusion
- Foetal abnormality
- Mothers with antibiotic medication during the allocation
- Couples with glucose 6-phosphate dehydrogenase enzyme deficiency
- Couples with known rhesus or haemolytic disease history
- Plan of place of birth at other hospitals other than Prince of Wales Hospital
- known breast disorder or any contraindication for breastfeeding.
Key Trial Info
Start Date :
March 23 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2025
Estimated Enrollment :
94 Patients enrolled
Trial Details
Trial ID
NCT06087874
Start Date
March 23 2024
End Date
June 1 2025
Last Update
May 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Prince of Wales Hospital
Hong Kong, New Territories, Hong Kong, 0852